A PHASE I-II STUDY OF BIALKYLATOR CHEMOTHERAPY, HIGH-DOSE THIOTEPA, AND CYCLOPHOSPHAMIDE WITH AUTOLOGOUS BONE-MARROW REINFUSION IN PATIENTS WITH ADVANCED CANCER

被引:64
|
作者
WILLIAMS, SF
BITRAN, JD
KAMINER, L
WESTBROOK, C
JACOBS, R
ASHENHURST, J
ROBIN, E
PURL, S
BESCHORNER, J
SCHROEDER, C
GOLOMB, HM
机构
[1] UNIV CHICAGO,DEPT MED,JOINT SECT HEMATOL ONCOL,AUTOLOGOUS BONE MARROW TRANSPLANT PROGRAM,CHICAGO,IL 60637
[2] UNIV CHICAGO,MICHAEL REESE HOSP & MED CTR,CHICAGO,IL 60616
关键词
D O I
10.1200/JCO.1987.5.2.260
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:260 / 265
页数:6
相关论文
共 50 条
  • [41] A phase I/II study of 4 monthly courses of high-dose cyclophosphamide and thiotepa for metastatic breast cancer patients
    T Bachelot
    F Gomez
    P Biron
    I Ray-Coquard
    P Soler-Michel
    I Philip
    J P Guastalla
    P Rebattu
    A Dumortier
    J P Droz
    J Y Blay
    British Journal of Cancer, 2002, 87 : 1079 - 1085
  • [42] A phase I/II study of 4 monthly courses of high-dose cyclophosphamide and thiotepa for metastatic breast cancer patients
    Bachelot, T
    Gomez, F
    Biron, P
    Ray-Coquard, I
    Soler-Michel, P
    Philip, I
    Guastalla, JP
    Rebattu, P
    Dumortier, A
    Droz, JP
    Blay, JY
    BRITISH JOURNAL OF CANCER, 2002, 87 (10) : 1079 - 1085
  • [43] PHASE-I STUDY OF HIGH-DOSE AMONAFIDE WITH AUTOLOGOUS BONE-MARROW RESCUE (ABMR)
    ELLIS, ED
    WILLIAMS, SF
    MOORMEIER, JA
    BITRAN, JD
    RATAIN, MJ
    CLINICAL RESEARCH, 1990, 38 (03): : A843 - A843
  • [44] HIGH-DOSE AZIRIDENYLBENZOQUINONE WITH AUTOLOGOUS BONE-MARROW TRANSPLANTATION - A PHASE-I STUDY IN ADULTS
    SPITZER, G
    VELLEKOOP, L
    ZANDER, AR
    JAGANNATH, S
    DICKE, KA
    EXPERIMENTAL HEMATOLOGY, 1984, 12 (06) : 461 - 461
  • [45] PHASE-I-II STUDY OF HIGH-DOSE MITOMYCIN WITH AUTOLOGOUS BONE-MARROW TRANSPLANTATION IN REFRACTORY METASTATIC BREAST-CANCER
    TANNIR, N
    SPITZER, G
    DICKE, K
    SCHELL, F
    DISTEFANO, A
    BLUMENSCHEIN, G
    CANCER TREATMENT REPORTS, 1984, 68 (05): : 805 - 806
  • [46] NONLINEAR PHARMACOKINETICS OF CYCLOPHOSPHAMIDE IN PATIENTS WITH METASTATIC BREAST-CANCER RECEIVING HIGH-DOSE CHEMOTHERAPY FOLLOWED BY AUTOLOGOUS BONE-MARROW TRANSPLANTATION
    CHEN, TL
    PASSOSCOELHO, JL
    NOE, DA
    KENNEDY, MJ
    BLACK, KC
    COLVIN, OM
    GROCHOW, LB
    CANCER RESEARCH, 1995, 55 (04) : 810 - 816
  • [47] HIGH-DOSE CHEMOTHERAPY WITH AUTOLOGOUS BONE-MARROW TRANSPLANTATION FOR EPITHELIAL OVARIAN-CANCER
    EXTRA, JM
    CURE, H
    VIENS, P
    MARANINCHI, D
    LEGROS, M
    MARTY, M
    BULLETIN DU CANCER, 1993, 80 (02) : 156 - 162
  • [48] HIGH-DOSE CHEMOTHERAPY WITH AUTOLOGOUS BONE-MARROW TRANSPLANTATION FOR METASTATIC BREAST-CANCER
    EDDY, DM
    HILLNER, BE
    SMITH, TJ
    DESCH, CE
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1992, 268 (12): : 1536 - 1537
  • [49] PHARMACOKINETICS OF MITOXANTRONE IN CANCER-PATIENTS TREATED BY HIGH-DOSE CHEMOTHERAPY AND AUTOLOGOUS BONE-MARROW TRANSPLANTATION
    RICHARD, B
    LAUNAYILIADIS, MC
    ILIADIS, A
    JUSTLANDI, S
    BLAISE, D
    STOPPA, AM
    VIENS, P
    GASPARD, MH
    MARANINCHI, D
    CANO, JP
    CARCASSONNE, Y
    BRITISH JOURNAL OF CANCER, 1992, 65 (03) : 399 - 404
  • [50] HIGH-DOSE CHEMOTHERAPY WITHOUT AUTOLOGOUS BONE-MARROW TRANSPLANTATION IN MELANOMA
    TCHEKMEDYIAN, NS
    TAIT, N
    VANECHO, D
    AISNER, J
    JOURNAL OF CLINICAL ONCOLOGY, 1986, 4 (12) : 1811 - 1818